CASP3 and breast carcinoma: One study demonstrated that restoration of caspase-3 expression, in caspase-3-deficient MCF-7 breast cancer cells, can sensitize to doxorubicin and etoposide-induced apoptosis, suggesting caspase-3 deficiency may be a possible mechanism for chemoresistance [93, 94].